Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an update.
Integral Diagnostics Ltd. has announced a change in the director’s interest notice for Ian Kadish, reflecting updates in the company’s securities holdings. The notice details the acquisition of 120,928 Short-Term Incentive (STI) Rights and 114,668 Long-Term Incentive (LTI) Rights, with no disposals reported. This change signifies an adjustment in the director’s performance rights, which may impact the company’s governance and incentive structures.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Average Trading Volume: 971,359
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$913.7M
For a thorough assessment of IDX stock, go to TipRanks’ Stock Analysis page.